Abbott has started delivering its BinaxNOW Covid-19 Ag Self-Test to retailers across the US. The test is expected to be available to customers on online platforms and at some retail stores such as CVS Pharmacy , Walmart, and Walgreens without a prescription. The self-test will be more broadly available in the upcoming two weeks. The company manufactures millions of self-tests per month and is looking at scaling capacity based on demand.
Therma Bright has received CE mark approval for its AcuVid Covid-19 rapid antigen saliva test. The company has also secured a conditional purchase order for 100,000 units through McWilliams Collective, a new global distribution partner. The order is secured for a large European client, on conditions that the company provides the initial test data which demonstrates 86%+ specificity and 100% sensitivity, and that the production levels are reached and delivered in June 2021.
RICOVR Healthcare has raised $1.5m to fund the commercialisation of its point-of-care testing device for both tetrahydrocannabinol (THC), a psychoactive constituent of cannabis, and Covid-19 disease. The company’s biosensor platform allows a small saliva sample to deliver results within just five minutes. The funding is expected to support the go-to-market goals for the XALIVA platform.